Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-05-26 Purchase | 2020-05-27 4:11 pm | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 10,256 | $9.75 | $99,996 | 824,845 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-11-19 Disposition | 2021-11-19 09:56 am | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,122,550 | $8.5 | 0 (Direct) | View |
2021-11-19 Disposition | 2021-11-19 09:56 am | N/A 2023-07-18 | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,474,297 | $0 | 0 (Direct) | View |
2021-07-19 Tax Withholding | 2021-07-20 8:44 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 13,859 | $0 | 1,122,033 (Direct) | View |
2021-06-21 Option Award | 2021-06-28 6:04 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,700 | $7.78 | 1,135,892 (Direct) | View |
2021-01-08 Gift | 2021-03-23 7:01 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 25,861 | $0 | 1,134,192 (Direct) | View |
2021-03-01 Option Award | 2021-03-03 6:16 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 265,250 | $0 | 1,293,342 (Direct) | View |
2021-01-28 Tax Withholding | 2021-01-29 8:17 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 8,776 | $12.37 | 1,028,092 (Direct) | View |
2021-01-27 Option Award | 2021-01-29 8:17 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 119,500 | $0 | 1,028,092 (Direct) | View |
2021-01-05 Tax Withholding | 2021-01-07 5:47 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 2,530 | $0 | 917,368 (Direct) | View |
2020-07-08 Gift | 2021-01-07 5:47 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,303 | $0 | 917,368 (Direct) | View |
2020-07-16 Option Award | 2020-07-20 9:26 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 93,750 | $0 | 919,898 (Direct) | View |
2020-06-22 Option Award | 2020-06-24 4:18 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 1,303 | $10.83 | 826,148 (Direct) | View |
2020-03-02 Option Award | 2020-03-03 4:10 pm | N/A 2030-03-01 | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 360,000 | $0 | 360,000 (Direct) | View |
2020-01-03 Tax Withholding | 2020-01-07 5:40 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 2,494 | $0 | 814,589 (Direct) | View |
2019-10-09 Gift | 2020-01-07 5:40 pm | N/A N/A | Flexion Therapeutics Inc | FLXN | Clayman Michael D. President and CEO | 15,855 | $0 | 814,589 (Direct) | View |